"Radiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
| Descriptor ID |
D018714
|
| MeSH Number(s) |
E02.186.775 E02.815.600
|
| Concept/Terms |
Radiotherapy, Adjuvant- Radiotherapy, Adjuvant
- Adjuvant Radiotherapy
- Adjuvant Radiotherapies
- Radiotherapies, Adjuvant
|
Below are MeSH descriptors whose meaning is more general than "Radiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Radiotherapy, Adjuvant".
This graph shows the total number of publications written about "Radiotherapy, Adjuvant" by people in this website by year, and whether "Radiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 4 | 4 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 6 | 6 |
| 2000 | 0 | 6 | 6 |
| 2001 | 3 | 7 | 10 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 7 | 8 |
| 2004 | 1 | 9 | 10 |
| 2005 | 1 | 5 | 6 |
| 2006 | 0 | 6 | 6 |
| 2007 | 0 | 10 | 10 |
| 2008 | 2 | 11 | 13 |
| 2009 | 2 | 11 | 13 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 10 | 10 |
| 2012 | 0 | 8 | 8 |
| 2013 | 0 | 10 | 10 |
| 2014 | 1 | 6 | 7 |
| 2015 | 3 | 8 | 11 |
| 2016 | 3 | 7 | 10 |
| 2017 | 4 | 8 | 12 |
| 2018 | 0 | 7 | 7 |
| 2019 | 5 | 5 | 10 |
| 2020 | 2 | 2 | 4 |
| 2021 | 0 | 10 | 10 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 4 | 4 |
| 2025 | 0 | 3 | 3 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiotherapy, Adjuvant" by people in Profiles.
-
Adjuvant Radiotherapy Does Not Improve Overall Survival After Negative Margin Resection of Sinonasal Epithelial-Myoepithelial Carcinoma. Am J Rhinol Allergy. 2026 Nov; 40(6):535-546.
-
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis. Lancet. 2026 03 14; 407(10533):1059-1071.
-
Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients. J Neurooncol. 2026 Feb 09; 176(3):201.
-
Trends in Nonsurgical Management for Low-Risk, Hormone Receptor-Positive Ductal Carcinoma In Situ. JAMA Netw Open. 2026 02 02; 9(2):e2558248.
-
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study). Int J Radiat Oncol Biol Phys. 2026 03 01; 124(3):676-685.
-
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data. Eur Urol. 2025 Sep; 88(3):277-290.
-
Adjuvant treatment in stage I clear cell endometrial carcinoma: A population-based study of survival outcomes. Gynecol Oncol. 2025 05; 196:85-91.
-
The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis. J Neurooncol. 2025 Feb; 171(3):629-636.
-
Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e500-e506.
-
Impact of proton versus photon adjuvant radiotherapy on overall survival in the management of skull base and spinal chordomas: a National Cancer Database analysis. J Neurosurg. 2025 01 01; 142(1):239-247.